COVID-19-associated Anxiety of Pregnant Women for Anomalies, Stillbirth and Preterm Labor

COVID-19-associated Anxiety of Pregnant Women for Anomalies, Stillbirth and Preterm Labor - CAASPtrial

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04568551

Acronym

CAASP

Enrollment

300

Registered

2020-09-29

Start date

2020-10-30

Completion date

2021-07-31

Last updated

2021-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety State

Brief summary

Capture of anxiety for anomalies, stillbirth and preterm Labor of pregnant women during COVID-19 pandemia

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* consenting ability

Exclusion criteria

* language barrier * uncompleted questionary

Design outcomes

Primary

Measure	Time frame	Description
anxiety for anomalies during COVID-19-pandemic and before (percentage difference in agreement to the items of the questionnaire)	6 months	Measurement of self-reported anxiety by a questionnaire and State-Trait Anxiety Inventory (STAI) and comparison with different empiric studies of anxiety for anomalies in pandemics
anxiety for stillbirths during COVID-19-pandemic and before (percentage difference in agreement to the items of the questionnaire)	6 months	Measurement of self-reported anxiety by a questionnaire and State-Trait Anxiety Inventory (STAI) and comparison with different empiric studies of anxiety for stillbirths in pandemics
anxiety for preterm labour during COVID-19-pandemic and before (percentage difference in agreement to the items of the questionnaire)	6 months	Measurement of self-reported anxiety by a questionnaire and State-Trait Anxiety Inventory (STAI) and comparison with different empiric studies of anxiety for preterm labour in pandemics

Countries

Germany

Outcome results